The Impact of Neutralizing Antibody Testing on The Cost-Effectiveness of Injectable Disease Modifying Treatments for Relapsing Remitting Multiple Sclerosis
Abstract
Authors
M Andreykiv A Plich A Prüfert L Heemstra A Van Engen